Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
LEXINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]
aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19
SAN DIEGO, May 12, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery […]
XP Inc. Reports 1Q20 Financial Results
SÃO PAULO, Brazil, May 12, 2020 (GLOBE NEWSWIRE) — XP Inc. (NASDAQ: XP) (“XP” or the “Company”), a leading, technology-driven […]
KemPharm Reports First Quarter 2020 Financial Results
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 5:00 p.m. ETCorporate and Regulatory Highlights:KP415 NDA […]
Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
– Conference Call Scheduled May 12, 2020 at 4:30 p.m. ET –– Following Recent Financing Cash Runway to End of […]
Progyny, Inc. Announces First Quarter 2020 Results
Company Well-Positioned to Successfully Manage COVID-Related ImpactsReports 72% Increase in First Quarter Revenue to $81.0 MillionReports $12.1 Million in Quarterly […]
Potbelly Corporation Reports Results for First Fiscal Quarter 2020
Company remains focused on the health and safety of employees, customers, franchisees, and communitiesPrior investments in Off-Premise & Digital, coupled […]
Arcutis Announces First Quarter 2020 Financial Results and Provides Business Update
Multiple important Phase 3 and Phase 2 data events anticipated during 2020/2021Arcutis currently expects no impact to its previously disclosed […]
Health Catalyst Reports First Quarter 2020 Results
SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and […]
Opiant Pharmaceuticals Announces First Quarter 2020 Financial Results and Corporate Update
SANTA MONICA, Calif., May 12, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines […]
